Psychiatry

Which interventions are actually effective for this common—but often well-hidden—issue.

Which statement about Jornay PM, a new formulation of methylphenidate for the treatment of attention-deficit hyperactivity disorder, is FALSE?

With a gut-wrenching wail that rippled from her body, Amber Walcker joined about a dozen screaming people in West Seattle who let their frustrations float away over the Puget Sound.

A surveyor asked me and a fellow doctor about rage rooms, prompting a reflection no how we, as physicians, should think about managing the complicated emotion of anger.

New article reviews evidence on cannabis use for commonly encountered mental health conditions and highlights groups at higher risk for harms from cannabis use.

Clinical trial compared selective serotonin reuptake inhibitor and metformin with placebo.

C-CHANGE panel develops new brain–heart guideline with 11 recommendations for screening and management to reduce risk in patients with both brain and heart diseases.

It’s the second verdict against Meta this week, after a jury in New Mexico determined the company harms children’s mental health and safety, in violation of state law.